Article
New York -"Measurement of IOP in 2006 is under pressure," Robert N. Weinreb, MD, told the Glaucoma 2006 meeting attendees here. "We need to reassess both the quality and the quantity of our IOP measurements.
RhyGaze secures Series A financing of $86 million to further novel gene therapy
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Ocugen announces positive 2-year safety and efficacy update of Phase 1/2 OCU400 for treatment of retinitis pigmentosa
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Samsara Vision announces positive intermediate-term visual and safety outcomes of SING IMT 6 months post-surgery
4DMT refocuses pipeline to prioritize 4D-150 trials in wet AMD and DME